Youth Risk Behavior Surveillance System |
YRBSS |
Clinical Trial: HIV and HCV Intervention In Drug Treatment Settings - 1
This study is currently recruiting patients.
Purpose
The purpose of this study is to test two strategies to reduce the risk of contracting Human Immunodeficiency Virus (HIV) or Hepatitis C Virus (HCV) by reducing risk behaviors in patients undergoing drug detoxification.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Behavior Therapy | Behavior: Behavior Therapy | Phase III |
MedlinePlus consumer health information
Study Type: Interventional
Study Design: Prevention, Uncontrolled
Official Title: HIV and HCV Intervention in Drug Treatment Settings
Expected Total Enrollment: 706
Study start: December 2003
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Criteria
Location and Contact Information
Colorado
Denver Health & Hosp Authority, Denver, Colorado, 80204 4507, United States; Recruiting
Island Grove RTC, Greeley, Colorado, 80631, United States; Recruiting
Massachusetts
SSTAR (Stanley St. Treatment & Resources, Inc), Fall River, Massachusetts, 02720, United States; Recruiting
Michigan
James Gilmore Jr. Treatment Center, Kalamazoo, Michigan, 49408, United States; Recruiting
Oregon
Willamette Family Treatment Services, Eugene, Oregon, 97402, United States; Recruiting
Willamette Family Treatment Services-Men's & Co-ed, Eugene, Oregon, 97408, United States; Not yet recruiting
Williamette Family Treatment Services, Buckley, Eugene, Oregon, 97402, United States; Not yet recruiting
Rhode Island
SSTAR of Rhode Island - North Kingstown, North Kingstown, Rhode Island, 02852, United States; Recruiting
Washington
Recovery Center King Co.-Kent Detox, Kent, Washington, 98032, United States; Recruiting
Recovery Center King Co.-Seattle Detox, Seattle, Washington, 98144, United States; Recruiting
Robert Booth, Ph.D., Principal Investigator, University of Colorado
More Information
Record last reviewed: January 2005
Last Updated: March 8, 2005
Record first received: January 27, 2005
ClinicalTrials.gov Identifier: NCT00102349
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Not Signed In -


